Autotransfusion Management During and After Cardiopulmonary Bypass Alters Fibrin Degradation and Transfusion Requirements

Overview

Journal J Extra Corpor Technol

Publisher EDP Sciences

Specialties Biotechnology
General Surgery
Health Services

Date 2007 Aug 4

PMID 17672185

Citations 5

Authors

Alice Wiefferink

Patrick W Weerwind

Waander van Heerde

Steven Teerenstra

Luc Noyez

Ben E de Pauw

Rene M H J Brouwer

Affiliations

Soon will be listed here.

Abstract

Unlabelled: The coagulation-fibrinolytic profile during cardiopulmonary bypass (CPB) has been widely documented. However, less information is available on the possible persistence of these alterations when autotransfusion is used in management of perioperative blood loss. This study was designed to explore the influence of autotransfusion management on intravascular fibrin degradation and postoperative transfusions. Thirty patients, undergoing elective primary isolated coronary bypass grafting, were randomly allocated either to a control group (group A; n=15) or an intervention group (group B; n=15) in which mediastinal and residual CPB blood was collected and processed by a continuous autotransfusion system before re-infusion. Intravascular fibrin degradation as indicated by D-dimer generation was measured at five specific intervals and corrected for hemodilution. In addition, chest tube drainage and need for homologous blood were monitored. D-dimer generation increased significantly during CPB in group A, from 312 to 633 vs. 291 to 356 ng/mL in group B (p = .001). The unprocessed residual blood (group A) revealed an unequivocal D-dimer elevation, 4131 +/- 1063 vs. 279 +/- 103 ng/mL for the processed residual in group B (p < .001). Consequently, in the first post-CPB period, the intravascular fibrin degradation was significantly elevated in group A compared with group B (p = .001). Twenty hours postoperatively, no significant difference in D-dimer levels was detected between both groups. However, a significant intra-group D-dimer elevation pre- vs. postoperative was noticed from 312 to 828 ng/mL in group A and from 291 to 588 ng/mL in group B (p < .01 for both). Postoperative chest tube drainage was higher in the patients from group A, which also had the highest postoperative D-dimer levels. Patients in group A perceived a higher need for transfusions of red cells suspensions postoperatively. These data clearly indicate that autotransfusion management during and after CPB suppresses early postoperative fibrin degradation.

Keywords: cardiopulmonary bypass, cardiotomy suction, coronary surgery, autotransfusion, fibrin degradation.

Citing Articles

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery.

Lloyd T, Geneen L, Bernhardt K, McClune W, Fernquest S, Brown T Cochrane Database Syst Rev. 2023; 9:CD001888.

PMID: 37681564 PMC: 10486190. DOI: 10.1002/14651858.CD001888.pub5.

Blood transfusion practices in cardiac anaesthesia.

Mangu H, Samantaray A, Anakapalli M Indian J Anaesth. 2014; 58(5):616-21.

PMID: 25535425 PMC: 4260309. DOI: 10.4103/0019-5049.144669.

The effect of salvaged blood on coagulation function as measured by thromboelastography.

Konig G, Yazer M, Waters J Transfusion. 2012; 53(6):1235-9.

PMID: 22934712 PMC: 3521840. DOI: 10.1111/j.1537-2995.2012.03884.x.

The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass.

Colli A, Balduzzi S, Ruyra X J Cardiothorac Surg. 2012; 7:55.

PMID: 22697396 PMC: 3410786. DOI: 10.1186/1749-8090-7-55.

Cell salvage for minimising perioperative allogeneic blood transfusion.

Carless P, Henry D, Moxey A, OConnell D, Brown T, Fergusson D Cochrane Database Syst Rev. 2010; (4):CD001888.

PMID: 20393932 PMC: 4163967. DOI: 10.1002/14651858.CD001888.pub4.

References

Aldea G, Soltow L, Chandler W, Triggs C, Vocelka C, Crockett G . Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002; 123(4):742-55. DOI: 10.1067/mtc.2002.120347. View

Sirvinskas E, Lenkutis T, Raliene L, Veikutiene A, Vaskelyte J, Marchertiene I . Influence of residual blood autotransfused from cardiopulmonary bypass circuit on clinical outcome after cardiac surgery. Perfusion. 2005; 20(2):71-5. DOI: 10.1191/0267659105pf792oa. View

Daane C, Golab H, Meeder J, Wijers M, Bogers A . Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume. Perfusion. 2003; 18(2):115-21. DOI: 10.1191/0267659103pf647oa. View

De Somer F, Van Belleghem Y, Caes F, Francois K, Van Overbeke H, Arnout J . Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2002; 123(5):951-8. DOI: 10.1067/mtc.2002.120334. View

Paparella D, Brister S, Buchanan M . Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004; 30(10):1873-81. DOI: 10.1007/s00134-004-2388-0. View

Comunale M, Carr J, Moorman R, Robertson L . Significance of D-dimer concentrations during and after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1996; 10(4):477-81. DOI: 10.1016/s1053-0770(05)80008-4. View

Weerwind P, Lindhout T, Caberg N, de Jong D . Thrombin generation during cardiopulmonary bypass: the possible role of retransfusion of blood aspirated from the surgical field. Thromb J. 2003; 1(1):3. PMC: 179879. DOI: 10.1186/1477-9560-1-3. View

Collen A, Koolwijk P, Kroon M, van Hinsbergh V . Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis. 2003; 2(2):153-65. DOI: 10.1023/a:1009240522808. View

Whitten C, Greilich P, Ivy R, Burkhardt D, Allison P . D-Dimer formation during cardiac and noncardiac thoracic surgery. Anesth Analg. 1999; 88(6):1226-31. DOI: 10.1097/00000539-199906000-00007. View

10.

Eisses M, Seidel K, Aldea G, Chandler W . Reducing hemostatic activation during cardiopulmonary bypass: a combined approach. Anesth Analg. 2004; 98(5):1208-16, table of contents. DOI: 10.1213/01.ane.0000108489.88613.2c. View

11.

Teufelsbauer H, Proidl S, Havel M, Vukovich T . Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost. 1992; 68(3):250-2. View

12.

Oliver J, Webb D, Newby D . Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol. 2005; 25(12):2470-9. DOI: 10.1161/01.ATV.0000189309.05924.88. View

13.

Sidelmann J, Gram J, Jespersen J, Kluft C . Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost. 2001; 26(6):605-18. DOI: 10.1055/s-2000-13216. View

14.

Wan S, Leclerc J, Vincent J . Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997; 112(3):676-92. DOI: 10.1378/chest.112.3.676. View

15.

Gunaydin S . Clinical significance of coated extracorporeal circuits: a review of novel technologies. Perfusion. 2004; 19 Suppl 1:S33-41. DOI: 10.1191/0267659104pf718oa. View

16.

Cross M . Autotransfusion in cardiac surgery. Perfusion. 2001; 16(5):391-400. DOI: 10.1177/026765910101600509. View

17.

Parolari A, Colli S, Mussoni L, Eligini S, Naliato M, Wang X . Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery. J Thorac Cardiovasc Surg. 2003; 125(2):336-43. DOI: 10.1067/mtc.2003.2. View

18.

Chandler W, Velan T . Plasmin generation and D-dimer formation during cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2004; 15(7):583-91. DOI: 10.1097/00001721-200410000-00009. View

19.

Fransen E, Maessen J, Dentener M, Senden N, Buurman W . Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999; 116(5):1233-9. DOI: 10.1378/chest.116.5.1233. View